Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B By Washington Examiner February 18, 2014 12:04 pm FacebookTwitterEmailPrint Add Washington Examiner on Google FacebookTwitterEmailPrint NEW YORK (AP) — Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B. TagsPharmaceutical Industry Related Content Faith, Freedom, and Self-Reliance Bloomberg uses its monopolistic power to attack fossil fuels Faith, Freedom, and Self-Reliance New Jersey and Virginia energy prices are about to go up House WATCH LIVE: House Democrats push to cut funding for Venezuela operations World Iran ends cooperation with UN watchdog IAEA seeking nuclear inspections In Focus Trump 2.0 so far gives reasons for gratitude and reasons for alarm
